Get the Stockscreener App
1.06
1.85%
-0.02
After Hours:
1.07
0.01
+0.94%
Cardiol Therapeutics Inc stock is traded at $1.06, with a volume of 277.23K.
It is down -1.85% in the last 24 hours and up +6.29% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$1.08
Open:
$1.08
24h Volume:
277.23K
Relative Volume:
0.62
Market Cap:
$118.38M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-3.1918
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
+4.95%
1M Performance:
+6.29%
6M Performance:
+2.91%
1Y Performance:
-19.70%
1-Day Range:
$1.04
$1.08
1-Week Range:
$0.9492
$1.10
52-Week Range:
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.06 | 120.61M | 0 | -21.65M | -15.84M | -0.3321 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Can Cardiol Therapeutics Inc generate free cash flow2025 Price Action Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
CRDL Stock Rating Reiterated at 'Buy' by HC Wainwright & Co. | C - GuruFocus
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright - MarketBeat
Cardiol Therapeutics Inc. - Baystreet.ca
Cardiol Therapeutics publishes phase II myocarditis study results - Investing.com
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure - TipRanks
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Investing News Network
Cardiol Therapeutics publishes phase II myocarditis study results By Investing.com - Investing.com India
Myocarditis trial finds CardiolRx reduced heart swelling marker - Stock Titan
How the (CRDL) price action is used to our Advantage (CRDL:CA) - Stock Traders Daily
Equities Analysts Set Expectations for CRDL FY2025 Earnings - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Stock Rating Upgraded by Brookline Cap M - MarketBeat
Analysts Offer Predictions for CRDL FY2025 Earnings - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% – Time to Sell? - Defense World
Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1%Time to Sell? - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Upgraded at Brookline Capital Management - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Raised to Strong-Buy at Brookline Capital Management - MarketBeat
(CRDL) Market Dynamics and Trading Signals (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics files underwriting agreement and warrant indenture By Investing.com - Investing.com Nigeria
Cardiol Therapeutics files underwriting agreement and warrant indenture - Investing.com
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing - TipRanks
Targets Report: Can Cardiol Therapeutics Inc weather a recessionPortfolio Profit Report & Daily Growth Stock Tips - baoquankhu1.vn
Fund Flows: Will Ambarella Inc stock benefit from M A2025 Trading Volume Trends & Safe Swing Trade Setups - baoquankhu1.vn
Aug Retail: Is MPWR in a bullish channel2025 Volatility Report & Daily Entry Point Trade Alerts - baoquankhu1.vn
(CRDL) Strategic Equity Report (CRDL:CA) - Stock Traders Daily
Can Cardiol Therapeutics Inc. weather a recessionJuly 2025 Analyst Calls & Verified Technical Trade Signals - mfd.ru
Cardiol Therapeutics Secures U.S. Patent for Heart Drugs - MSN
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs - TipRanks
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Investing News Network
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Investing News Network
When the Price of (CRDL) Talks, People Listen (CRDL:CA) - Stock Traders Daily
Heart disease biotech Cardiol raises $14.85M for trials - stocktitan.net
Cardiol Therapeutics Inc. announced that it has received CAD 13.500001 million in funding - marketscreener.com
(CRDL) Equity Trading Insights (CRDL:CA) - Stock Traders Daily
Top Canadian Stocks to Buy Right Away With $5,000 - Yahoo! Finance Canada
Cardiol Therapeutics announces $13.5M bought-deal private placement - MSN
Will Cardiol Therapeutics Inc. (CT9) stock gain from lower interest ratesChart Pattern Recognition & Free Discover Fast Growing Stocks - bollywoodhelpline.com
Why Cardiol Therapeutics Inc. stock is favored by top institutionsCup and Handle Formations & Identify Breakout Stocks - bollywoodhelpline.com
Portfolio Shifts: Will Cardiol Therapeutics Inc outperform tech stocksTake Profit & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Cardiol Therapeutics announces $13.5 million private placement By Investing.com - Investing.com Nigeria
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com - Investing.com Nigeria
Cardiol Therapeutics Inc. announced that it expects to receive CAD 13.500001 million in funding - marketscreener.com
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs - TipRanks
Cardiol Therapeutics announces $13.5 million private placement - Investing.com
Cardiol Therapeutics announces $13.5 million bought deal financing - Investing.com
Heart drug developer Cardiol lines up $13.5M to fund trials and research - Stock Titan
AI Stocks: Is NeuroSense Therapeutics Ltd Equity Warrant forming a bullish divergenceJuly 2025 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5%Still a Buy? - MarketBeat
(CRDL) On The My Stocks Page (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):